☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Across
Roche Highlights its Bispecific Antibody Portfolio Across a Range of Blood Cancers at ASH 2020
December 9, 2020
Foundation Medicine's FoundationOne CDx Receives the US FDA's Approval as a CDx for Vitrakvi (larotrectinib)
October 26, 2020
AstraZeneca Expands the Development of AZD1222 into P-III Study in the US Across All Adult Age Groups
September 1, 2020
Bayer and One Drop Collaborate to Develop Digital Therapies Across Multiple Therapeutic Areas
August 24, 2020
Roche Reports the US FDA's Acceptance of sBLA for Xolair (omalizumab) Prefilled Syringe for Self-Administration Across All Indicat...
August 13, 2020
Bayer Signs a Research and License Agreement with Curadev to Develop Novel STING Antagonists Across Multiple Indications
March 23, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.